login

Pulse wave velocity as endpoint in large-scale intervention trial. The Complior® study

Journal of HypertensionPublished 1 April 2001
Roland Asmar, Jirar Topouchian, Bruno Pannier, Athanase Bénétos, Michel E. Safar
Citations151
SJR quartileQ1
SJR score1.10
SNIP1.63

TL;DR

The Complior Study is the first study to show the feasibility of a large-scale intervention trial using PWV as the endpoint in hypertensive patients, and results may be obtained using an automatic device and rigorous criteria for assessment.

Abstract

The Complior Study is the first study to show the feasibility of a large-scale intervention trial using PWV as the endpoint in hypertensive patients. Adequate results may be obtained using an automatic device and rigorous criteria for assessment. A long-term controlled intervention study is needed to confirm the results of the present uncontrolled trial.

Keywords

Medicine